Hepatitis B, hepatitis C, and mortality among HIV-positive individuals

Alicia Thornton(The Royal Free Hospital), Caroline Sabin(Primary Health Care), Sanjay Bhagani, Mark Gompels, Stephen Kegg(South London Healthcare NHS Trust), Chris Taylor(King's College Hospital), Sophie José(NHS England), Achim Schwenk(Roland Hill (United Kingdom)), Clifford Leen, Richard Gilson(University College London), Mark Nelson(University of Tasmania), Alison Rodger(Royal Free London NHS Foundation Trust), Janice Main(St Mary's Hospital), Elaney Youssef(Roland Hill (United Kingdom)), David Chadwick(Lancaster University), David Dunn(Indiana University – Purdue University Indianapolis)
AIDS
September 18, 2017
10.1097/qad.0000000000001646
Cited by 88

Related Papers

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987